Evaluation of corticospinal axon loss by fluorescent dye tracing in mice with experimental autoimmune encephalomyelitis

被引:14
作者
Liu, Zhongwu [1 ]
Li, Yi [1 ]
Zhang, Jing [1 ]
Elias, Stanton [1 ]
Chopp, Michael [1 ,2 ]
机构
[1] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA
[2] Oakland Univ, Dept Phys, Rochester, MI USA
关键词
Dil; corticospinal tract; experimental autoimmune encephalomyelitis; axon loss; mice;
D O I
10.1016/j.jneumeth.2007.08.013
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In both multiple sclerosis (MS) patients and experimental autoimmune encephalomyelitis (EAE) animals, axon loss has been demonstrated to correlate with neurological disability. However, it is difficult to accurately determine the location and severity of axonal damage since the lesion in MS or EAE is disseminated and is frequently in a relapsing-remitting mode. The corticospinal system is the only direct pathway from the motorsensory cortex to the spinal cord, and the major neural pathway for control of voluntary movement. Moreover, it is frequently involved in the pathological process of the disease. To evaluate corticospinal tract (CST) axon loss in EAE mice, we developed a direct tracing method with a fluorescent neuronal tracer Dil which was injected into the primary motor cortex and sensorimotor cortex to label the pyramidal neurons. The lesion location in the spinal cord and axon disruption were indicated by dye leakage. Using the EAE induced axon reduction as an index of the extent of axonal damage, our data showed a high correlation between the axonal loss and the behavioral outcome score in the EAE mice. The results were consistent with the axonal Bielschowsky silver staining. Thus, this CST tracing method permits monitoring of the axonal damage in EAE. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 39 条
[1]   Magnetic resonance spectroscopy: imaging axonal damage in MS [J].
Arnold, DL .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 98 (01) :2-6
[2]   Axonal protection achieved in a model of multiple sclerosis using lamotrigine [J].
Bechtold, David A. ;
Miller, Sandra J. ;
Dawson, Angela C. ;
Sun, Yue ;
Kapoor, Raju ;
Berry, David ;
Smith, Kenneth J. .
JOURNAL OF NEUROLOGY, 2006, 253 (12) :1542-1551
[3]   Building different mouse models for human MS [J].
Bettelli, Estelle .
HOW DO WE BEST EMPLOY ANIMAL MODELS FOR TYPE 1 DIABETES AND MULTIPLE SCLEROSIS?, 2007, 1103 :11-18
[4]  
Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO
[5]  
2-2
[6]   Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease [J].
Bjartmar, C ;
Wujek, JR ;
Trapp, BD .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (02) :165-171
[7]   Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE [J].
Black, Joel A. ;
Liu, Shujun ;
Hains, Bryan C. ;
Saab, Carl Y. ;
Waxman, Stephen G. .
BRAIN, 2006, 129 :3196-3208
[8]  
BROWN LT, 1971, EXP BRAIN RES, V13, P432
[9]   Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis - Results of a longitudinal magnetic resonance spectroscopy study [J].
De Stefano, N ;
Matthews, PM ;
Fu, LQ ;
Narayanan, S ;
Stanley, J ;
Francis, GS ;
Antel, JP ;
Arnold, DL .
BRAIN, 1998, 121 :1469-1477
[10]   Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts [J].
DeLuca, GC ;
Ebers, GC ;
Esiri, MM .
BRAIN, 2004, 127 :1009-1018